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Herewe identify a componentof thenuclearRNAcap-
binding complex (CBC), Ars2, that is important for
miRNA biogenesis and critical for cell proliferation.
Unlikeother componentsof theCBC,Ars2expression
is linked to theproliferative stateof thecell.Deletionof
Ars2 is developmentally lethal, and deletion in adult
mice led tobonemarrow failurewhereasparenchymal
organs composed of nonproliferating cells were unaf-
fected. Depletion of Ars2 or CBP80 from proliferating
cells impaired miRNA-mediated repression and led
to alterations in primary miRNA processing in the
nucleus. Ars2 depletion also reduced the levels of
several miRNAs, including miR-21, let-7, and miR-
155, that are implicated in cellular transformation.
These findings provide evidence for a role for Ars2 in
RNA interference regulation during cell proliferation.
INTRODUCTION
Arsenic resistance protein 2 (Ars2/Asr2) was originally cloned in
a screen for cDNAs that could confer sodium arsenite resistance
in a hamster cell line (Rossman and Wang, 1999), but the protein
has remained poorly characterized. It is conserved throughout
metazoa and has homologs in plants and fission yeast, but not
budding yeast. Ars2 deletion in metazoans is associated with
developmental lethality in Drosophila (Oh et al., 2003), zebrafish
(Golling et al., 2002), and mouse (Wilson et al., 2008). Mutations
of SERRATE, a plant gene with homology to Ars2, result in broad
developmental defects and hypersensitivity to the plant stress
hormone abscisic acid, whereas enforced expression of
SERRATE enhances plant growth (Bezerra et al., 2004; Grigg
et al., 2005; Prigge and Wagner, 2001).
Several lines of evidence support a role for Ars2 in RNA metab-
olism. First, Ars2 contains a number of domains, including an328 Cell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc.amino-terminal arginine-rich domain, a central RNA-binding
domain, and a zinc finger, that are common in RNA-binding
proteins. Second, SERRATE was recently found to be required
for the biogenesis of miRNAs in Arabidopsis (Grigg et al., 2005;
Lobbes et al., 2006; Yang et al., 2006). Third, reports have iden-
tified Ars2 as a component of RNA-protein complexes enriched
for spliceosomes (Rappsilber et al., 2002; Zhou et al., 2002).
The current experiments began by investigating the role of Ars2
in mediating cell survival in response to arsenic treatment. Unlike
the reported partial clone, a full-length Ars2 cDNA did not confer
arsenic resistance. To examine the possibility that the partial clone
had functionedasa dominant negative in previous studies, wesup-
pressed Ars2 using RNAi and observed increased survival of cells
treated with arsenic. However, Ars2 suppression led to a profound
defect in cell proliferation. To investigate the molecular basis of the
essential role for Ars2 in proliferation, we studied the expression,
localization, and biochemical properties of Ars2. These studies
reveal that Ars2 interacts with the nuclear CBC and components
of the nuclear pri-miRNA processing complex. Unlike the core
components of the CBC, CBP80 and CBP20, Ars2 is not constitu-
tively expressed. Ars2 is selectively expressed in proliferating cells
and its expression is required for the maintenance of cell prolifera-
tion. Ars2 expression contributes to the stability and delivery of
capped primary miRNA transcripts to the pri-miRNA processing
complex containing Drosha and DGCR8 (Pasha). Furthermore,
depletion of Ars2 is sufficient to reduce the pri-miRNA processing
and miRNA levels of a number of miRNAs, including miR-21, let-7,
and miR-155, implicated in transformation. Together, these data
suggest that Ars2 is a proliferation-inducible component of the
CBC that contributes to regulation of RNA interference.
RESULTS
Ars2 Modulates Arsenic Sensitivity
and Colony Formation
When we isolated Ars2 cDNAs from a murine hematopoietic cell
line the clones obtained had an open reading frame coding for
a predicted protein of 875 amino acids, in contrast to the 225
amino acids coded for by the open reading frame of the cDNA
originally isolated (Rossman and Wang, 1999). The predicted
Figure 1. Ars2 Is Required for Cell Prolifera-
tion
(A) 3T3 MEFs were infected with retroviral shRNA
targeted to Ars2 (shArs2-1) or control empty
vector (shVec) and expanded for 4 days. Western
blot analysis was performed to determine Ars2
protein levels and actin as a loading control.
(B) Cells were infected with retroviral shRNAs
(shVec and shArs2-1) and treated with arsenic
trioxide at the doses indicated for 48 hr, and
viability was determined by DAPI exclusion and
FACS analysis (mean ± standard deviation [SD]).
(C) MEF stable clones were generated expressing
vector control shRNA (two representative clones
shown; vec-7, vec-12) or shRNAs targeting two
independent sequences of Ars2 (hp1-11, hp2-9).
Ars2 protein levels were determined.
(D) The proliferative potential of the MEF stable
shRNA clones (vec-7, vec-12, hp1-11, hp2-9)
was measured by colony-forming assay in 12-
well plates and the number of colonies per well is
plotted. The experiment was performed in tripli-
cate and the data are expressed as mean ± SD.
(E) 3T3 MEFs were infected with retroviral shRNAs
to Ars2 (shArs2-1, shArs2-2) or vector control
(shVec) and expanded for 4 days to allow deple-
tion of Ars2 protein to occur and then plated
for the proliferation assay. Western blotting was
performed from cell extracts collected on day 1.
(F) 3T3 cells were infected with retroviral shRNAs
as in (E) and plated for proliferation assay. Popula-
tion doublings were determined as described in
Experimental Procedures. The data represent
mean ± SD of triplicate samples.
(G) Cells were infected with shVec or shArs2-1 as
in (E), then subjected to serum starvation overnight
in 0.1% serum followed by serum stimulation
(10% FBS) in the presence of BrdU for 12 hr.
BrdU incorporation was determined by FACS.
protein contained an amino-terminal argi-
nine-rich domain and an RNA recognition
motif in addition to the carboxy-terminal
zinc finger domain originally identified.
When expressed in either murine fibro-
blasts or the human cell line K562, this
clone of Ars2 resulted in no increase in
resistance to arsenic trioxide compared
to control transfected cells at a range of
doses (data not shown).
Since the original reported Ars2 clone
appeared to be a truncation of the full-
length gene product, we reasoned that it
may have functioned as a dominant
negative. As determined by western blot
analysis, 3T3 mouse embryonic fibro-
blasts (MEFs) infected with shRNA to
Ars2 (shArs2-1) showed effective deple-
tion of the protein after 4 days in culture, compared to cells
treated with empty vector control retrovirus (shVec) (Figure 1A).
When Ars2-depleted cells were treated with arsenic trioxide forCell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc. 329
48 hr the cells exhibited a slower rate of cell death when
compared to control infected cells treated with arsenic (Fig-
ure 1B). However, few of the cells infected with Ars2 shRNA
were able to proliferate when subsequently passaged in
arsenic-free medium (data not shown).
To extend these findings, 3T3 clonal cell lines were generated
(hp1-11 and hp2-9) expressing shRNAs targeted to two indepen-
dent sequences within the Ars2 mRNA. These stable cell line
clones showed reduced levels of Ars2 in comparison to two
different vector control clonal cell lines (vec-7, vec-12) (Fig-
ure 1C). The sensitivity of these cell lines to arsenic trioxide was
assessed by colony-forming assay. Ars2 knockdown cell lines
consistently formed one-half the number of colonies as control
cell lines (Figure 1D).
Ars2 Is Required for Cell Proliferation
The inability of viable Ars2-deleted cells to recover following
treatment with arsenic trioxide suggested the possibility that
these cells had a proliferative defect. 3T3 MEFs were treated
with Ars2 shRNA and population doublings measured over
time in culture. shArs2-1 caused a near complete loss of detect-
able Ars2 protein (Figure 1E) and suppressed proliferation for
4 days in culture, whereas shArs2-2 caused a lesser amount of
Ars2 depletion and had a more modest effect on cell proliferation
(Figures 1E and 1F). The proliferative defect of Ars2-deficient
cells was associated with a reduced ability of Ars2 knockdown
cells to incorporate BrdU following serum stimulation (Figure 1G).
Ars2-deficient cells did not arrest at a particular stage in the cell
cycle or exhibit a significant amount of cell death until after they
had ceased progressing through the cell cycle.
To independently confirm the effects of Ars2 on proliferation,
a floxed allele of Ars2 was generated in murine embryonic stem
cells by homologous recombination (Figure S1 available online).
Injection of these cells into blastocysts resulted in chimeric
animals and further breeding established mice homozygous for
the targeted allele (Ars2flox/flox) from which MEFs were generated
and immortalized by transfection with SV40 large T antigen.
Genetic deletion of Ars2 in the Ars2flox/flox (fl) MEFs was
accomplished by infecting the cells with a retrovirus expressing
Cre recombinase. By 72 hr post-infection, Ars2 protein levels
were significantly diminished compared to wild-type (WT)
MEFs infected with Cre (Figure 2A). Prior to this time point, there
was no difference in the number of cells that had accumulated in
culture. However, between 72 and 120 hr post-infection, the
number of Ars2flox/flox cells that had accumulated was signifi-
cantly diminished compared to WT cells (Figure 2B). Over this
timecourse, there was an inhibition of cell proliferation compa-
rable to that observed using Ars2 shRNA.
Analysis of Ars2 expression in vivo revealed high expression in
hematopoietic tissues and reduced or absent expression in
parenchymal organs like liver and kidney (Figure 2C and data
not shown). To examine the effects of Ars2 deletion in prolifer-
ating tissues in vivo, Ars2flox/ mice were crossed to mice
harboring an MxCre transgene to obtain mice of the compound
genotype Ars2fl/; MxCre (fl/; MxCre). The MxCre transgene
has been used to mediate inducible recombination in a wide
variety of tissues and with high efficiency in the liver and hema-
topoietic compartments (Kuhn et al., 1995). Injection of these330 Cell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc.mice with the nucleotide analog polyinosinic-polycytidylic acid
(pIpC) led to induction of Cre recombinase and deletion at the
Ars2 locus as evidenced by western analysis from hematopoietic
tissues (Figure 2C, lane 6). Mice harboring one WT allele and one
floxed allele of Ars2 (fl/WT) served as controls and did not have
depletion of the Ars2 protein, even in the presence of the MxCre
transgene (Figure 2C, lanes 4 and 5). Histological examination of
Ars2flox/; MxCre mice sacrificed 9 days after pIpC treatment re-
vealed decreased bone marrow cellularity compared to control
(fl/) injected mice (Figure 2D). Other hematopoietic organs
including the thymus and spleen showed histological evidence
of increased apoptosis (not shown). In contrast, the histology
of other organs including the liver, heart, brain, kidney, and lungs
was unaffected in both Ars2flox/; MxCre and control mice
following pIpC injections (Figure 2D and data not shown).
Despite the ability of MxCre to induce recombination in liver
following pIpC (Kuhn et al., 1995), liver function tests including
serum alanine aminotransferase and alkaline phosphatase levels
did not show significant differences between fl/; MxCre and
control mice following pIpC injection.
Ars2 Interacts with the Nuclear Cap-Binding Complex
To gain further insight into Ars2 function a biochemical screen for
interacting proteins was performed. Flag-Ars2 was transiently
transfected into 293T cells and immunopurified with anti-Flag
antibody. Coprecipitated proteins were identified by liquid chro-
matography coupled to mass spectrometry. Two proteins that
specifically enriched with Flag-Ars2 immunoprecipitation (IP)
but not with control immunoprecipitation were identified: the
80 kDa subunit of the nuclear cap-binding complex (CBC) and
importin a.
Immunoprecipitation of Flag-Ars2 followed by western blot
analysis with specific antibodies confirmed that Ars2 coprecipi-
tates the 80 kDa subunit of the nuclear CBC (CBP80) as well as
the 20 kDa CBC subunit (CBP20) and importin a/b heterodimeric
nuclear import receptor (Figure 3A). Importin a has been previ-
ously shown to be a constitutive component of the nuclear
CBC (Gorlich et al., 1996). Under the conditions tested Flag-
Ars2 did not coimmunoprecipitate other molecules that have
been reported to bind the nuclear CBC, including the mRNA
export adaptor ALY/REF (Cheng et al., 2006) or the nonsense-
mediated decay factor Upf1 (Hosoda et al., 2005) (data not
shown). Furthermore, Ars2 did not coimmunoprecipitate the
cytoplasmic 7-methyl guanosine (7mG)-associated complexes
eIF4A or eIF4E (data not shown), nor the highly abundant RNA-
binding protein hnRNP A1 (Figure 3A).
To verify that Ars2 interacts with the nuclear CBC, Flag-tagged
CBP80 was immunopurified from transfected 293T cells using
anti-Flag antibody. Ars2 was enriched along with other CBC
complex components in this immunoprecipitate (Figure 3B).
Furthermore, the sedimentation profiles of endogenous Ars2
and CBP80 proteins were compared using sucrose gradient
analysis. Ars2 was concentrated in the light fractions, whereas
CBP80 was detected throughout the gradient with a significant
amount unresolved in the pellet fraction (Figure 3C). Sucrose
gradient analysis carried out in the presence of RNase A revealed
that both Ars2 and CBP80 sedimentation profiles collapsed to
fractions 3 to 5 at the top of the gradient (Figure 3C). Despite
Figure 2. Ars2 Genetic Deletion Causes Proliferative Arrest and Bone Marrow Hypoplasia
(A) Ars2flox/flox (fl) and wild-type (WT) control MEFs were infected with retrovirus expressing Cre recombinase and expanded for 72 hr and then protein extracts
were analyzed by western blot.
(B) WT and fl MEFs were infected with retroviral Cre as in (A). Between 72 and 120 hr after infection population doublings were measured by modified 3T3 assay.
The data presented are the mean ± SD of triplicate samples.
(C) In vivo deletion of Ars2 was achieved by injection of 6- to 8-week-old mice with polyinosinic-polycytidylic acid (pIpC) every other day over a 2 week period.
Mice bearing one floxed allele of Ars2 (fl) and one null allele () (fl/) were crossed to mice harboring an MxCre transgene to create mice with the compound
genotype fl/; MxCre. Controls included mice of the genotypes fl/WT and fl/WT; MxCre. The mice were sacrificed 9 days after the last injection and tissues
(spleen, liver) were harvested for protein extraction. Ars2 levels were determined by western blot.
(D) pIpC injection was performed as in (C) and mice were sacrificed 9 days after the last pIpC injection. Liver and bone marrow were harvested and histological
staining was performed with hematoxylin and eosin.the observation that Ars2 sedimentation profiles were sensitive
to RNase A treatment, the ability of Ars2 to coimmunoprecipitate
with CBP80 was not dependent on RNA. Immunoprecipitation of
Flag-Ars2 in the presence of RNase A did not abolish the Ars2-
CBC interaction (Figure 3D). In contrast, a small amount of
eIF4G immunoprecipitated by Ars2 was found to be sensitive
to RNase treatment and served as a positive control for RNase
A activity (Figure 3D).
Ars2 Interacts with 7-Methyl Guanosine-Capped RNAs
To confirm that endogenous Ars2 interacts with the nuclear
CBC, the ability of Ars2 antibodies to induce a gel shift in
CBC-RNA assembly reactions was examined. Using previously
published conditions (Izaurralde et al., 1992), a 7mG-dependent
gel shift of capped and radiolabeled RNA probe was resolved by
native gel electrophoresis (Figure 4A, complex, lane 3). This shift
was 7mG dependent as a significantly diminished shift was
observed using 2,2,7-trimethylguanosine (TMG)-capped RNAs(Figure 4A, lane 4), for which the nuclear CBC has a low affinity.
The 7mG-dependent shift has been reported to contain the
nuclear CBC complex proteins CBP80 and CBP20 (Izaurralde
et al., 1995). This was confirmed by incubating assembly reac-
tions with a rabbit antibody raised against full-length CBP20,
which resulted in an inhibition of the 7mG-dependent shift
(data not shown) as has been previously reported for similar
antibodies (Izaurralde et al., 1995). An Ars2-specific antibody
reproducibly supershifted a fraction of the RNA-binding complex
(Figure 4A, supershift, lane 11). A supershift was not observed
with control rabbit antiserum (lanes 5–8), with TMG-capped
RNA (lanes 2, 4, 6, 8, 10, 12), or in the absence of nuclear extract
(lanes 1, 2, 5, 6, 9, and 10).
The protein components of the CBC shuttle between the
nucleus and the cytoplasm. If Ars2 is associated with the CBC
during nuclear export it should also undergo shuttling. Expres-
sion of V5-tagged Ars2 in 3T3 MEFs showed Ars2 to be
a predominately nucleoplasmic protein, with faint staining ofCell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc. 331
Figure 3. Ars2 Interacts with the Nuclear Cap-Binding Complex
(A) 293T cells were transfected with Flag-Ars2 (F-Ars2) and immunoprecipitations were performed with anti-Flag beads. Following elution with Flag peptide
proteins were fractionated by SDS-PAGE and detected by western blot using the antibodies indicated. Untransfected cells (Mock) were used as a control.
Approximately 3% of the protein loaded into the IP was run as input.
(B) Anti-Flag immunoprecipitation from 293T cells transiently transfected with Flag-CBP80 (F-80) followed by Flag peptide elution, SDS-PAGE, and western
blotting using the antibodies indicated. One-half of the input material was loaded for Ars2 western blot compared to the other western blots.
(C) Sucrose gradient (5%–20%) analysis of 3T3 MEF whole-cell extracts was carried out in the presence or absence of RNase A. Each fraction was separated by
SDS-PAGE followed by western blotting for Ars2 and CBP80. The percent of sucrose in the fractions increases from left to right as indicated. P indicates pellet.
(D) Anti-Flag immunoprecipitations were carried out in the presence or absence of RNase A and analyzed by SDS-PAGE and western blotting. The data are repre-
sentative of three independent experiments.the cytoplasm (data not shown). In heterokaryon shuttling exper-
iments, MEFs stably expressing V5-tagged Ars2 were fused to
HeLa cells in the presence of cycloheximide to inhibit new
protein synthesis. After 2 hr, immunofluorescence showed that
Ars2 had accumulated in HeLa nuclei of heterokaryons
(Figure 4B, upper panels). Addition of leptomycin B to inhibit
Crm1-dependent nuclear export strongly decreased the shut-
tling of Ars2 (Figure 4B, lower panels).
Ars2 and the Nuclear CBC Are Required
for miRNA-Mediated RNA Interference
The data suggest that Ars2 binds the nuclear CBC (Figures 3 and
4A). In Arabidopsis, mutations in genes encoding the plant
homologs of CBP80 (called ABH1) and Ars2 (SERRATE) have
similar phenotypes (Bezerra et al., 2004; Hugouvieux et al.,332 Cell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc.2001; Papp et al., 2004). Mutation of SERRATE is proposed to
result in developmental defects because of its required role in
the processing of miRNAs (Grigg et al., 2005).
Based on these observations the effect of Ars2 on miRNA-
mediated gene silencing in mammalian cells was tested. Two
luciferase reporters that are sensitive to let-7-mediated miRNA
repression were used. The first (‘‘lin28 site’’) contains Renilla
luciferase with three let-7 target sites in the 30UTR derived
from the lin28 transcript. The second (‘‘perfect match’’) is a
similar construct with the lin28 site mutated to be perfectly
complementary to let-7 to trigger Argonaute 2 (Ago2)-dependent
slicer activity and reporter mRNA cleavage. Transfection of
siRNAs was first performed to deplete Ars2 or CBP80 from
HeLa cells (Figure S2), and then the cells were transfected with
the reporter constructs. siRNAs to Ago2 were used as a control
and caused a 1.5- to 2-fold loss of repression compared to
control siRNAs for both reporters (Figure 5A). Two siRNAs tar-
geted to Ars2 (Ars2-1, Ars2-2) or siRNA to CBP80 inhibited
miRNA-mediated repression to an equal or greater extent
compared to Ago2 siRNA for the lin28 site reporter and had
a significant, but lesser, effect on the perfect match reporter (Fig-
ure 5A). A mutant reporter with a single base pair insertion in the
lin28 site seed region to disrupt let-7 binding led to a loss of
repression under all conditions tested and verified that our assay
was responsive to let-7 (data not shown). Addition of excess
let-7/let-7* duplex to the transfection mix rescued the loss of
repression afforded by Ars2, but not Ago2, depletion (Figure 5B).
Figure 4. Like Other CBC Components, Ars2 Interacts with 7mG-
Capped RNAs and Shuttles in a Crm1-Dependent Fashion
(A) Ars2 assembles on RNAs in a cap-dependent manner. Gel shift assay was
performed with in vitro transcribed, radiolabeled probe RNA containing either
7-methylguanosine (7) or 2,2,7-trimethylguanosine (T) caps incubated with
HeLa nuclear extract as indicated. RNA-bound complexes were resolved
by native PAGE. Rabbit IgG or Ars2 antibodies were added to the assembly
reactions as indicated. Unbound probe (unbound), the cap-binding complex
shift (complex), and the supershift detected with Ars2 antibody (supershift)
are indicated. The data are representative of four independent experiments.
(B) Ars2 shuttling between the nucleus and cytoplasm is leptomycin B sensi-
tive. 3T3 MEFs with stable expression of Ars2-V5 were fused to HeLa cells
in the presence of cycloheximide (CHX) or cycloheximide plus leptomycin B
(LMB) as indicated. DAPI counterstaining allowed HeLa and 3T3 nuclei to be
distinguished. Arrowheads indicate 3T3 nuclei and arrows indicate HeLa
nuclei.Depletion of either Ars2 or DGCR8 with two independent
siRNAs led to a decrease in let-7 miRNA levels compared to
control treated cells (Figures 5C and 5D). miR-21, another miRNA
whose expression has also been implicated in the regulation of
cell proliferation, was also decreased by depletion of Ars2 from
cells. Although pre-let-7 was not detectable by northern blotting,
depletion of Ars2 protein also led to a clear reduction of pre-miR-
21 (Figure S3). However, not all miRNAs were similarly affected;
the levels of several housekeeping miRNAs were not found to
be affected by depletion of Ars2 (Figure S3).
In the nucleus, primary miRNA transcripts are processed by
the Microprocessor complex that contains Drosha and
DGCR8, whereas Dicer functions to process pre-miRNAs in
the cytoplasm. To determine whether Ars2 could interact with
either the Dicer or Drosha processing complexes, immunopre-
cipitation of Flag-Drosha and Flag-Dicer was performed from
293T cells. Western blotting on these immunoprecipitates re-
vealed that endogenous Ars2 and CBP80 coprecipitated with
Drosha but not Dicer (Figure 6A). RNase A treatment failed to
disrupt coprecipitation of endogenous Ars2 and CBP80 with
Drosha. Similarly when extracts from 293T cells transfected
with V5-tagged Ars2 (V5-Ars2) were used for immunoprecipita-
tion, Drosha was coprecipitated (Figure 6B).
To test whether miRNA maturation downstream of Drosha was
preserved in the absence of Ars2 or CBP80, the let-7-responsive
luciferase reporters were transfected into cells in the presence or
absence of excess pre-let-7 that is not dependent on Drosha for
activity. When Ars2, CBP80, or Ago2 were depleted from cells
a loss of let-7-mediated repression was observed for both
lin28 site and perfect match reporters (Figure 6C). Addition of
excess pre-let-7 to the transfection mix rescued the loss of
repression in cells that had been depleted of Ars2 or CBP80
for both reporters (Figure 6C). When the levels of endogenous
pri-miRNA transcripts were analyzed, depletion of either Ars2
or CBP80 led to a decrease in pri-miR-21 RNA (Figure 6D). In
contrast, as previously reported (Gregory et al., 2004; Han
et al., 2004; Landthaler et al., 2004), depletion of DGCR8 led to
increased levels of pri-miR-21 compared to control treated cells
as detected by RT-PCR (Figure 6D).
The above data indicate that the Ars2/CBC complex may be
involved in the stability of pri-miRNAs and/or their processing.
Recently, the plant Ars2 homolog SERRATE has been implicated
in regulating the fidelity of pri-miRNA processing by the DCL1
complex (Dong et al., 2008). To assess whether Ars2 plays
a similar role in mammalian cells, primary miRNA processing
assays were performed. As shown in Figure 6E, when pri-miR-
155 (pri) was incubated with a 293T extract under processing
conditions, a cleavage product of approximately 65 nucleotides
(pre) was obtained that was indistinguishable from that gener-
ated by incubation with immunopurified Drosha complexes,
whereas control immunoprecipitations contained no activity.
Extract prepared from MEF cells gave rise to a cleavage product
identical to that generated by immunopurified Drosha com-
plexes (Figure 6E).
To determine if Ars2 contributed to the primary miRNA
processing activity in MEFs, extracts were generated from
Ars2flox/flox cells infected with Cre recombinase (KO). These KO
extracts contained diminished processing activity compared toCell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc. 333
Figure 5. Ars2 and CBC Contribute to miRNA-Mediated Gene Silencing
(A) HeLa cells were transfected with the siRNAs indicated and 48 hr later transfected with lin28 site or perfect match renilla luciferase reporters along with firefly
luciferase as a normalization control. Luciferase activity was analyzed 16 hr after transfection and is presented as a ratio of renilla/firefly. The experiment was
performed in triplicate and error bars represent standard deviation. * indicates p < 0.03 in comparison to control.
(B) HeLa cells were transfected with siRNAs and 48 hr later luciferase reporters were transfected as in (A) (no addition) or with excess let-7/let-7* duplex included
in the transfection mix (+ let-7). * indicates p < 0.01. Error bars indicate mean ± SD.
(C) HeLa cells were transfected with siRNAs and harvested after 72 hr. Total RNA was fractionated by 15% urea-PAGE and blotted using specific probes to the
RNAs indicated.
(D) Quantitation of (C) was performed by phosphorimager or densitometry with equivalent results. Data represent mean ± SD of two independent experiments.control extracts prepared from WT cells infected with Cre re-
combinase, which generated the correct 65 nucleotide cleavage
product (Figures 6F and S4A). KO extracts generated a substan-
tial fraction of cleavage products of smaller size than that gener-
ated by WT extracts. No processing was observed in the
absence of extract. Quantitation of the indicated pri and pre
bands revealed that KO extracts contained approximately 3-
fold less correct processing activity compared to WT extracts
(Figure 6G). Comparable results were obtained with pri-miR-21.
Ars2 and CBC Are Differentially Regulated
during Cell Quiescence and Proliferation
To examine whether Ars2 is a constitutive component of the
nuclear CBC or a more specialized component, the expression
of Ars2 and other components of the CBC was examined as cells
underwent transitions between quiescence and proliferation.
MEFs undergoing exponential proliferation in 10% serum con-334 Cell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc.tained readily detectable protein levels of CBP80 and CBP20,
as well as Ars2. However, upon serum starvation in 0.1% serum
for 48 hr, a treatment that causes exit from the cell cycle, Ars2
protein levels decreased substantially (Figure 7A). Under the
same conditions, levels of nuclear CBC were only modestly
affected. As a control, the levels of actin were slightly increased
by serum starvation whereas the levels of the RNA-binding
protein hnRNP A1 were unchanged (Figure 7A).
Regulation of Ars2 protein levels was also examined in an
independent cell system. Hematopoietic cells derived from
Bax/Bak/ mice have been shown to reliably exit the cell
cycle upon IL-3 withdrawal and then re-enter cell proliferation
in a synchronized fashion following restimulation with IL-3
(Lum et al., 2005). Cells maintained in the presence of IL-3 (day 0)
had a mean resting cell size of approximately 700 femtoliters (fL)
that rapidly declined upon IL-3 withdrawal as the cells exited the
cell cycle. In these cultures proliferation reproducibly ceased
Figure 6. Ars2 Functions at the Level of the
Primary miRNA Transcript
(A) Anti-Flag immunoprecipitations were performed
from 293T cells transfected with plasmids encoding
Flag-Dicer or Flag-Drosha or nontransfected cells
(Mock). Bound protein complexes were eluted
with Flag peptide and fractionated by SDS-PAGE,
and western blotting was performed with the indi-
cated antibodies. RNase A was added as indicated.
Input represents 1% of the material added to the IP.
Data are representative of three independent exper-
iments.
(B) Anti-V5 immunoprecipitations were performed
from 293T cells transfected with the indicated plas-
mids. Proteins were eluted in loading buffer, frac-
tionated by SDS-PAGE, and probed with the anti-
bodies indicated.
(C) Luciferase assays were performed as in
Figure 5B, except excess pre-let-7 was included in
the transfection mix (+ pre-let-7). The experiment
was performed in triplicate and error bars represent
standard deviation. * indicates p < 0.01.
(D) HeLa cells were transfected with siRNAs and
harvested after 72 hr. RT-PCR and qRT-PCR were
performed for the transcripts indicated. Data are
representative of three independent experiments.
RQ indicates relative quantitation in comparison to
actin. Error bars represent SD of triplicate samples.
* indicates p < 0.01 in comparison to control.
(E) Primary miRNA processing assay. Radiolabeled
pri-miR-155 was incubated with the cell extracts or
immunoprecipitates indicated and RNAs were
resolved by 12% urea-PAGE followed by autoradi-
ography. Primary miRNA substrate (pri) and product
(pre) are indicated. Flag-Drosha was immunopre-
cipitated from transfected 293T cells. Flag Control
indicates IP performed on mock-transfected 293T
cells using anti-Flag antibody.
(F) miRNA processing assay was performed on
extracts prepared from wild-type (WT) or Ars2flox/flox
MEFs (KO) infected with Cre retrovirus for 72 hr and
results determined by autoradiography as above.
(A lighter exposure to visualize the pri-miRNAs is
included in Figure S4A.)
(G) Quantitation of (F). Error bars indicate the
average deviation of three independent experi-
ments. Pri and pre bands were quantitated by expo-
sure of dried gels to phosphorimager in two cases
and exposure to film and densitometry in one case.
The ratio pre/(pri+pre) is plotted.3 days later (Figure 7B). Cell size then slowly declined as the cells
engaged in macroautophagy to survive over the next 11 days in
culture. At day 14 IL-3 was added back to the medium and the
cells began to reaccumulate cell mass without proliferating. By
day 18 the cells had achieved their original cell size and prolifer-
ation resumed 1 day later (Figure 7B). Ars2 was highly expressed
at day 0 in the presence of IL-3 and was depleted by day 3 when
proliferation ceased (Figure 7C). Furthermore, Ars2 protein levels
were not initially induced during cell growth (days 15–18) but
became highly expressed upon resumption of proliferation at
day 19 (Figure 7C). In contrast, the levels of CBP20 did not corre-
late with cell proliferation, cell growth, or quiescence and were
maintained invariantly throughout the course of the experiment.CBP80 levels were maintained for a longer period following
growth factor withdrawal than Ars2 levels but quickly recovered
upon IL-3 readdition during the cell growth phase (days 15–18).
Whether the downregulation of Ars2 protein levels associated
with withdrawal from the cell cycle affected the ability to process
proliferation-associated miRNAs was investigated using primary
miRNA processing assays. Extracts prepared from MEFs under-
going proliferation in 10% serum efficiently processed a miR-155
pri-miRNA substrate to the correct pre-miRNA product (Fig-
ure 7D). In contrast, extracts from cells cultured in 0.1% serum
for 48 hr gave rise to a decreased proportion of correctly pro-
cessed pre-miRNA products and increased heterogeneity of
the products of primary miRNA processing (Figure 7D). ToCell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc. 335
Figure 7. Nonproliferating Cells Downregulate Ars2 and Display
Altered miRNA Processing
(A) Exponentially growing MEFs were switched to 0.1% serum for 48 hr or
maintained in 10% serum and protein levels of Ars2, CBP80, and CBP20
were analyzed by SDS-PAGE and western blot. Actin and hnRNP A1 were
probed as controls.
(B) IL-3-dependent Bax/Bak/ hematopoietic cells were grown in IL-3 at
day 0, then subjected to IL-3 withdrawal for a period of 2 weeks followed by
restimulation with IL-3 at day 14.5. At the time points indicated cell size and
cell number were determined. Points at which cell proliferation ceased and
resumed are noted above the graph, as is the point of growth factor readdition.
fL = femtoliters.
(C) At the times indicated, aliquots from (B) were removed from the culture for
protein extraction and western analysis using antibodies to Ars2, CBP80, and
CBP20. The periods of growth factor (IL-3) withdrawal and readdition are
noted. The data are representative of four independent experiments.
(D) Primary miRNA processing assay. Pri-miR-155 was incubated with or
without extracts of MEFs cultured in 10% or 0.1% serum for 48 hr. RNA was
resolved by 12% urea-PAGE followed by autoradiography. Primary miRNA
substrate (pri) and product (pre) are indicated.336 Cell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc.determine whether the alteration in primary miRNA processing
observed during cell-cycle arrest could be rescued by addition
of excess Ars2 protein, extracts prepared from MEFs cultured
in 0.1% serum were mixed with extracts prepared from WT or
Ars2-depleted (KO) MEFs grown in 10% serum, and primary
miRNA processing assays were performed. Mixture of extract
from WT cells grown in 0.1% serum with extract from WT cells
grown in 10% serum gave rise to correctly processed pre-
miRNAs when incubated with pri-miR-155 substrate (Figure S4).
In contrast, mixture of extract from WT cells grown in 0.1%
serum with extract from KO cells grown in 10% serum failed to
generate properly processed pre-miRNAs.
DISCUSSION
The above studies demonstrate that the Ars2 protein plays a crit-
ical role in the ability of mammalian cells to proliferate. In the
absence of Ars2, mammalian cells are incapable of maintaining
proliferative expansion in vitro. Consistent with a critical role in
proliferation, Ars2 is selectively expressed in proliferating cells.
In the absence of Ars2, cells undergo cell-cycle slowing at all
stages of the cell cycle as evidenced by impairment of prolifera-
tion without discernable changes in the cell-cycle profile (Figure 2
and data not shown). A biochemical screen for Ars2-interacting
proteins yielded CBP80, a protein previously shown to assemble
on 7mG-capped transcripts. Further immunoprecipitation ex-
periments revealed that Ars2 efficiently immunoprecipitates
both core components of the CBC, CBP80 and CBP20.
An independent line of evidence supporting Ars2-CBC inter-
actions comes from studies of Arabidopsis. Plants deficient in
SERRATE, an Ars2 homolog, partially phenocopy plants with
CBP80 (ABH1; ABA HYPERSENSITIVE 1) mutations. Both plants
have pleiotropic developmental defects including increased
cauline leaf number and serrated leaf morphology (Bezerra
et al., 2004). SERRATE has been genetically implicated in
a nuclear step of miRNA biogenesis in plants, and SERRATE-
deficient plants have reduced mature miRNA levels (Grigg
et al., 2005; Lobbes et al., 2006; Yang et al., 2006). To examine
whether Ars2, as a constituent of the nuclear CBC, might have
a similar effect on miRNA-mediated gene silencing in prolifer-
ating cells we examined the ability of Ars2 to affect let-7-medi-
ated repression in proliferating cells. Suppression of either
CBP80 or Ars2 was sufficient to disrupt let-7-mediated repres-
sion of a reporter transcript (Figure 5). These effects are likely
due to a defect in miRNA biogenesis as Ars2-depleted cells
had decreased levels of a subset of miRNAs including let-7
and miR-21. In contrast, miR-30a, which is implicated in the
regulation of hepatobiliary development (Hand et al., 2008),
and miR-16, which has been implicated in the regulation of
apoptosis and proliferation (Cimmino et al., 2005; Linsley et al.,
2007), were not affected by depletion of Ars2 (Figure S3).
Several lines of evidence indicate that Ars2 functions at the
level of the primary miRNA transcript to promote miRNA matura-
tion. The decreased levels of primary miRNA transcripts in the
absence of Ars2 are different from the effect of Drosha or
DGCR8 depletion, which causes stabilization of primary tran-
scripts (Figure 6D; Denli et al., 2004; Gregory et al., 2004; Han
et al., 2004; Landthaler et al., 2004; Lee et al., 2003). This
suggests that Ars2 and CBC contribute to the stability of pri-
miRNAs in proliferating cells. As the CBC binds and protects
the 50 cap structure of PolII transcripts, depletion of Ars2 or
CBC may lead to increased decapping and transcript decay.
As demonstrated in the accompanying manuscript (Sabin
et al., 2009 [this issue of Cell]), Ars2 and the CBC are also
required for miRNA function in Drosophila cells and interact
with Drosophila homologs of the evolutionarily conserved Micro-
processor complex. In addition, Sabin et al. demonstrated in
Drosophila that Ars2 and CBP20 are required for miRNA pro-
cessing at the level of the pri-miRNA and that pri-miRNA levels
decline in the absence of Ars2. Because the nuclear CBC is
cotranscriptionally recruited to nascent transcripts (Visa et al.,
1996; Wong et al., 2007) it is ideally positioned to promote
recruitment of the Microprocessor complex to pri-miRNA tran-
scripts. However, the observed alteration in pri-miRNA process-
ing in Ars2-depleted extracts argues for a more direct role for
Ars2 in modulating the activity of the Microprocessor complex.
Consistent with our findings, recent work in plants has shown
that the Ars2 homolog SERRATE increases the processing effi-
ciency and accuracy of DCL1 in vitro (Dong et al., 2008). Sabin
et al. also report decreased processing activity of Dcr-2 in
extracts depleted of Drosophila Ars2. Taken together, these
observations suggest that Ars2 homologs may contribute to
the regulation of RNase III enzyme complexes in several species.
The data from Sabin et al. in the accompanying paper suggest
that Ars2 also is a required component of small RNA-mediated
viral suppression. While depletion of Ars2 from adult flies had
no effect on organismal viability under baseline conditions,
a requirement for Ars2 emerged during viral infection. Adult flies
do not depend on cell proliferation for organismal viability or viral
immunity. Thus, Ars2 may play an inducible role in small RNA
regulation in nonproliferating cells when infected. Based on the
data, it appears that Ars2 is not essential for miRNA processing
during cell quiescence but is required to maintain the efficiency
of miRNA-mediated silencing as cells commit to engage in cell
division or are subjected to viral infection. Recent studies have
shown that translational repression of target mRNAs by miRNAs
is relieved upon exit from the cell cycle (Vasudevan et al., 2007).
Induction of Ars2 expression upon entry to cell proliferation may
regulate the repression of genes specific to states of cellular
quiescence. Alternatively, as cells engage in increased and
more complex gene expression associated with cell division,
compensatory upregulation of the efficiency or specificity of
miRNA production may be required to meet the complex
demands of exponential growth.
EXPERIMENTAL PROCEDURES
Cell Lines, Transfection, and Retrovirus
HeLa, immortalized MEFs, and HEK293T were maintained in Dulbecco’s
Modified Eagles Medium (DMEM) supplemented with 10% heat-inactivated
fetal bovine serum, 10 U/ml penicillin/streptomycin, and 10 mM HEPES.
IL-3-dependent cell lines derived from Bax/Bak/ mice were maintained
as previously described (Lum et al., 2005). Plasmid transfections were per-
formed with Lipofectamine 2000 and reverse transfection of siRNAs were per-
formed with Lipofectamine RNAiMAX. Retrovirus for mammalian infection was
generated by cotransfection of HEK293T cells with pCL-Eco helper virus and
retroviral constructs and infections were performed as described (Zong et al.,2003). Cell proliferation, cell size, and viability were determined as previously
described (Lum et al., 2005).
Colony Formation Assay and Cell-Cycle Analysis
Cells were plated at a density of 100 cells per well of a 12-well plate and main-
tained for 10 days without changing the media. Cells were fixed with ice-cold
methanol and stained with 0.5% crystal violet. Cell-cycle analysis was per-
formed as previously described (Fox et al., 2003).
Immunoprecipitation, Western Blotting, Sucrose Gradients,
and Gel Shifts
Cells were lysed in RIPA and western blots were prepared as previously
described (Fox et al., 2003). Antibodies used were anti-Ars2 (custom made
by Quality Controlled Biochemicals using a peptide corresponding to amino
acids 76–93 of mouse Ars2), actin (Santa Cruz), CBP80 and CBP20 (gener-
ously provided by Iain Mattaj), importin-a (5C9), anti-importin-b (BD Biosci-
ences), and hnRNP A1 (4B10). For immunoprecipitation cells were lysed in
RSB-100 buffer (10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2.5 mM MgCl2) con-
taining 0.02% Triton X-100. Immunoprecipitation was carried out with FLAG
M2 agarose or anti-V5 antibody. For gradients, extracts were prepared in
BC100 buffer (100 mM KCl, 0.2% NP-40, 10% glycerol, 20 mM Tris, pH 7.5,
0.5 mM DTT) and centrifuged at 33,000 rpm for 15 hr and 20 min at 4C using
a SW41 Ti rotor. Equal volumes of each fraction were analyzed. For gel shifts,
in vitro transcription of U1DSm DNA template was performed in the presence
of 7mG or TMG cap analog and 32P-UTP. Conditions for CBC gel shift reac-
tions were based on previously published works (Izaurralde et al., 1992;
Ohno et al., 1990).
Northern Blotting and RT-PCR
Total RNA was fractionated on 15% Urea-PAGE gels and transferred to
Hybond+ membrane and crosslinked by UV irradiation. Hybridization of
32P-end-labeled DNA oligonucleotide probes antisense to let-7 or miR-21
was performed using Ultrahyb-Oligo buffer (Ambion) at 37C overnight. For
RT-PCR, total RNA was subject to reverse transcription using Superscript II
Reverse Transcriptase. A range of PCR cycle numbers were examined to
determine the range of linear amplification for each primer pair. For specific
primer sequences, see the Supplemental Experimental Procedures.
Heterokaryon Assay
3T3 cells expressing Ars2-V5 were seeded together with HeLa cells on cover-
slips. Cycloheximide (50 mg/ml) was applied 30 min prior to fusion and
throughout the experiment. Cells were fused with 50% polyethylene glycol
8000 in DMEM for 2 min, then washed extensively and incubated for a further
2 hr at 37C in complete media. Immunofluorescence was performed using
anti-V5 antibody as previously described (Zong et al., 2003).
Generation of Ars2flox Mice
The locus was targeted for Cre-recombinase-mediated deletion by flanking the
region between Exons 2 through 19 with LoxP sites (Figure S1). Two correctly
targeted and karyotypically normal clones were injected into C57Bl/6 blasto-
cysts to obtain chimeric mice, which were bred to C57Bl/6 females to obtain
germline transmission. The resulting heterozygous offspring harboring the tar-
geted allele were interbred to mice heterozygous for the Ars2 constitutive null
allele and subsequently to mice carrying the MxCre transgene. Ars2flox/flox,
Ars2flox/, and Ars2flox/WT mice developed normally and appeared healthy.
In vivo deletion was induced by intraperitoneal administration to 6- to 8-week-
old mice of 100 mg pIpC every other day for a total of three times per week
for 2 consecutive weeks. Animals were sacrificed 9 days after the last injection.
Luciferase Assays
Twenty-four hours after siRNA transfection, HeLa cells were split and 24 hr
later transfected with luciferase reporters with or without 20 pmol of let-7/
let-7* duplex or 10 pmol pre-let-7. Let-7 reporters were previously described
as lin-28-M1 (‘‘mutant’’), lin-28-WT (‘‘lin28 site’’), and let7-TA (‘‘perfect match’’)
(Kiriakidou et al., 2005). pGL3 was cotransfected to normalize for transfection
efficiency and cell number. Let-7/let-7* duplex was prepared by annealing let-
7a and let-7a* synthetic RNAs (Dharmacon); these RNAs and pre-let-7a wereCell 138, 328–339, July 24, 2009 ª2009 Elsevier Inc. 337
described previously (Maniataki and Mourelatos, 2005). Cells were harvested
16 hr after transfection and processed with Promega Dual Luciferase Assay
reagents.
Primary miRNA Processing Assay
To generate pri-miR-155, substrate PCR was performed using primers flank-
ing the pre-miR-155 hairpin of the human locus. The T7 promoter was incorpo-
rated into the forward primer. PCR was performed using a plasmid containing
the full-length human pri-miR-155 sequence as a template and the product
was used for in vitro transcription in the presence of 32P-UTP. Cell extracts
were prepared by lysing cells in Microprocessor buffer (100 mM KCl, 20 mM
Tris [pH 7.5], 0.2 mM EDTA, 0.01% Triton X-100) followed by sonication and
centrifugation. A 30 ml processing reaction containing 15 ml of cell extract or
IP material, 10.25 ml of water, 6.4 mM MgCl2, and 10,000 C.P.M. of radiola-
beled substrate was incubated at 37C for 90 min. RNA was extracted with
Trizol and resolved by 12% urea-PAGE.
Statistical Methods
Error bars of experiments performed in triplicate or duplicate indicate standard
deviation. p values were calculated using paired, two-tailed Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and four
figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(09)00507-8.
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